Furthermore, cathepsin L expression was limited to the insulin-producing cells in the tumor tissue, indicating a beta-cell origin of cathepsin L expression in the MycERTAM;Bcl-xL tumor model (Fig 2B). The gene discussed is BCL2L1; the disease is neoplasm.